IDEX stock is up 23.5% year to date, yet there is a clear split between what the Discounted Cash Flow (DCF) intrinsic value suggests and what traditional market multiples say, with the stock screening undervalued on the DCF view but overvalued on earnings based ratios. That gap, alongside a mixed overall value score, puts the current US$221.07 share price under closer scrutiny.

• Year to date, IDEX has returned 23.5%, which puts recent price strength front and centre in any valuation discussion.
• For IDEX, investors are weighing the potential for steady cash generation from its industrial portfolio against the risk that growth or margins do not keep pace with what the current valuation already implies.
• The stock passes 3 of 6 valuation checks, which is a mixed picture rather than a clear bargain or clear overvaluation. You can see the detail behind that score on 3/6 valuation checks.

The issue now is whether IDEX's current price leans closer to the intrinsic value indicated by the Discounted Cash Flow (DCF) work, which points to roughly 22.0% upside, or to the richer view implied by its market multiples.

Is IDEX Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) approach looks at what IDEX’s future cash generation could be worth in today’s dollars. In this framework, the company’s latest twelve month free cash flow sits at about US$604.7 million, with the model assuming that free cash flow grows over time from this base rather than shrinking.

Feeding those cash flows into a 2 Stage Free Cash Flow to Equity model leads to an estimated intrinsic value of about $283 per share, compared with the current share price of roughly $221. That gap implies the stock trades at around a 22.0% discount to what the DCF suggests its cash flows might justify, even after a strong run so far this year.

On these cash flow assumptions, IDEX stock currently appears undervalued relative to its DCF based intrinsic value estimate.

Our Discounted Cash Flow (DCF) analysis suggests IDEX is undervalued by 22.0%. Track this in your watchlist or portfolio, or discover 45 more high quality undervalued stocks.

Has IDEX Run Too Far on Earnings?

P/E is a useful cross check for IDEX because earnings remain a central focus for many investors looking at industrial businesses. On this measure, IDEX trades on a P/E of about 32.2x, very close to the peer average of 32.4x and above the broader Machinery industry average of 27.5x. On simple comparisons, the stock therefore sits toward the higher end of the sector’s earnings valuations rather than at a discount.

The fair P/E ratio, which adjusts for factors such as growth profile, margins, size and risk, is estimated at 26.5x. That is meaningfully below the current 32.2x level. This indicates investors are paying a higher price for each dollar of IDEX earnings than this framework implies is warranted. While this does not indicate where the share price will move next, it does suggest the market-multiple view is less forgiving than the DCF analysis.

On the P/E multiple, IDEX stock currently screens as overvalued relative to its tailored fair ratio benchmark.

The IDEX Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for IDEX take the valuation gap you have just seen and turn it into a set of clear, testable stories about what IDEX's future growth, margins and earnings would need to look like for the stock to be worth materially more or less than today's price, and these sit on Simply Wall St's Community page. Each narrative links a fair value estimate to a particular view of IDEX's potential catalysts and risks, so you can see over time which version of events is closer to what actually happens.

Share a narrative on IDEX's valuation, present a data-driven case on the potential direction of its growth, margins and execution from here, and see how your view compares as new results and market reactions emerge.

Do you think there's more to the story for IDEX? Head over to our Community to see what others are saying!

The Bottom Line

For IDEX, the Discounted Cash Flow (DCF) work points to meaningful upside on an intrinsic value basis, while the earnings multiple view flags the stock as overvalued compared with its tailored fair P/E. That split reflects different levers, with the DCF leaning on cash flow durability and capital needs, and the P/E view anchored in how much growth and sentiment are already embedded in today’s pricing. With broader checks sitting in the middle, the key question from here is whether IDEX can sustain the growth and margin profile implied by its current P/E without eroding the cash flow support that the intrinsic value estimate assumes.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.